Drug Description in Trials / DrugBank / KEGG DRUG

Search results

descriptions per page:

Showing 1 to 10 of 12 descriptions

Filter by |

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[4] 2, 4, 6, 70 💬

2

Dexmedetomidine
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[14] 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬

Disease ID	Name
2	Amyotrophic lateral sclerosis
4	Primary lateral sclerosis
6	Parkinson disease
21	Mitochondrial disease
34	Neurofibromatosis
46	Malignant rheumatoid arthritis
70	Spinal stenosis
107	Juvenile idiopathic arthritis
113	Muscular dystrophy
171	Wilson disease
212	Tricuspid atresia
215	Tetralogy of Fallot
226	Interstitial cystitis with Hunners ulcer
280	Huge arteriovenous malformation with cervicofacial or limb lesion

3

Dexmedetomidine 1
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 280 💬

4

Dexmedetomidine 2
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 280 💬

5

Dexmedetomidine 3
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 280 💬

6

Dexmedetomidine group
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 70 💬

7

Dexmedetomidine Hcl 100 Mcg/mL Inj
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 215 💬

8

DEXMEDETOMIDINE HYDROCHLORIDE
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 70 💬

9

Dexmedetomidine Hydrochloride Infusion
(Dexdor (TN))

[1] Dexmedetomidine (Dexdor)

[1] Dexmedetomidine (Dexdor (TN)) 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 6 💬

10

Dexmedetomidine with ropivacaine
(Dexdor (TN))

[2] Dexmedetomidine (Dexdor),
Ropivacaine

[2] Dexmedetomidine (Dexdor (TN)),
Ropivacaine 💬

[8] ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬

Name	Full Name
ADRA2A	adrenoceptor alpha 2A
ADRA2B	adrenoceptor alpha 2B
ADRA2C	adrenoceptor alpha 2C
SCN1A	sodium voltage-gated channel alpha subunit 1
SCN2A	sodium voltage-gated channel alpha subunit 2
SCN3A	sodium voltage-gated channel alpha subunit 3
SCN5A	sodium voltage-gated channel alpha subunit 5
SCN9A	sodium voltage-gated channel alpha subunit 9

[5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor intera ...

[1] 70 💬

First Previous1 2Next Last